Toxicology Reagent DRI® Benzodiazepine (BZO) CLIA Non-Waived For Clinical Chemistry Analyzers

Name: Toxicology Reagent
Brand: DRI®

REAGENT, IMMUNOASSAY DRI BENZODIAZEPINE SERUM 25X8ML D/S

McKesson #

1254949

Manufacturer #

0920

Brand

DRI®

Manufacturer

Fisher Scientific

Country of Origin

Unknown

Application

Toxicology Reagent

CLIA Classification

CLIA Non-Waived

CLIA Classified

CLIA Non-Waived

Container Type

Bottle

For Use With

For Clinical Chemistry Analyzers

Form

Ready-to-Use Liquid

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Sample Type

Serum Sample

Specialty

Toxicology

Storage Requirements

Requires Refrigeration

Test Category

Drugs of Abuse

Test Method

Homogenous Enzyme Immunoassay (HEIA)

Test Name

Benzodiazepine (BZO)

UNSPSC Code

41116007

Volume

R1: 25 mL, R2: 8 mL

The DRI® Benzodiazepine Serum Tox Assay is intended for the qualitative and semiquantitative determination of benzodiazepines in human serum or plasma with a 50 ng/mL cutoff
Serum-based assay
Liquid, ready-to-use and has the flexibility to run on a variety of clinical chemistry analyzers